How are OTC and direct-to-consumer infectious disease diagnostics expanding access to testing?
Advances in diagnostic technology are making certain health tests more convenient and accessible for consumers. Over-the-counter (OTC) and direct-to-consumer (DTC) infectious disease diagnostics are helping broaden access to testing while supporting timely health decisions and public health initiatives.
OTC and DTC infectious disease diagnostics include test kits that allow eligible consumers to collect samples or perform specific tests outside of traditional clinical settings, depending on the product's intended use and regulatory authorization. These products are designed with clear instructions to support proper use, but results should always be interpreted according to the manufacturer's guidance. Individuals should seek advice from qualified healthcare professionals when symptoms persist, results are unclear, or additional medical evaluation is recommended.
One of the biggest trends is the integration of rapid diagnostic technologies, digital health platforms, smartphone connectivity, artificial intelligence–supported result interpretation, and secure data management. Manufacturers are also improving ease of use, expanding test availability, and enhancing quality assurance while supporting regulatory standards and responsible healthcare innovation.
It's encouraging to see how diagnostic innovation is improving access to testing while complementing professional medical care.
What do you think will have the greatest impact on the future of OTC and DTC infectious disease diagnostics—AI-assisted digital diagnostics, connected home testing solutions, or faster next-generation rapid testing technologies?